Cargando…

Vemurafenib and cutaneous adverse events - report of five cases

Vemurafenib is a selective inhibitor of V600E-mutant BRAF protein used to treat metastatic and unresectable melanoma. Clinical trials have shown increased overall survival and progression-free survival in patients treated with Vemurafenib. However, cutaneous adverse events are common during treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Giselle de Barros, Mendes, Adriana Pessoa, de Macedo, Mariana Petaccia, Pinto, Clóvis Antônio Lopes, Gibbons, Ivana Lameiras, Duprat Neto, João Pedreira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540563/ https://www.ncbi.nlm.nih.gov/pubmed/26312729 http://dx.doi.org/10.1590/abd1806-4841.20153841

Ejemplares similares

Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience
por: Gibbons, Ivana Lameiras, et al.
Publicado: (2018)

Intraoperative assessment of surgical margins using “en face” frozen sections in the management of cutaneous carcinomas()
por: Otsuka, Ana Carolina Vasconcellos Guedes, et al.
Publicado: (2022)

How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system()()
por: Antonialli, Amanda Zorzetto, et al.
Publicado: (2020)

Dermatofibrosarcoma protuberans of the vulva: margins assessment and reconstructive options – a report of two cases
por: Bertolli, Eduardo, et al.
Publicado: (2014)

Learning Reflectance Confocal Microscopy of Melanocytic Skin Lesions through Histopathologic Transversal Sections
por: Braga, Juliana Casagrande Tavoloni, et al.
Publicado: (2013)

Proliferating trichilemmal cyst with clinical, radiological, macroscopic, and microscopic correlation
por: Valerio, Ediel, et al.
Publicado: (2019)

Recurrent halo nevus: Dermoscopy and confocal microscopy features
por: Porto, Ana Carolina, et al.
Publicado: (2017)

Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil
por: Porto, Ana Carolina, et al.
Publicado: (2020)

Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma
por: de Haan, Jorine, et al.
Publicado: (2018)

Multiple Primary Melanoma: A Five-Year Prospective Single-Center Follow-Up Study of Two MC1R R/R Genotype Carriers
por: Sortino, Ana Maria Fagundes, et al.
Publicado: (2023)

Hotspot analysis by confocal microscopy can help to differentiate challenging melanocytic skin lesions
por: Castro, Raquel de Paula Ramos, et al.
Publicado: (2022)

3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells
por: Vital, Patrik da Silva, et al.
Publicado: (2022)

Ruptured hepatic metastases of cutaneous melanoma during treatment with vemurafenib: an autopsy case report
por: Nosaka, Takuto, et al.
Publicado: (2015)

Metastatic melanoma and vemurafenib: novel approaches
por: De Mello, Ramon Andrade
Publicado: (2012)

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016)

Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel()()
por: Cury-Martins, Jade, et al.
Publicado: (2020)

Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib
por: Nowara, Elzbieta, et al.
Publicado: (2016)

Scurvy in a patient on vemurafenib
por: Gerstenblith, Meg R., et al.
Publicado: (2014)

Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis
por: Sandri, Silvana, et al.
Publicado: (2023)

Primary cutaneous follicle center lymphoma simulating basal-cell carcinoma on the nasal ala
por: Wanczinsnki, Mariana Isis, et al.
Publicado: (2015)

Hereditary melanoma: a five-year study of Brazilian patients in a cancer referral center - phenotypic characteristics of probands and pathological features of primary tumors
por: de Sá, Bianca Costa Soares, et al.
Publicado: (2018)

Melanoacanthoma: a potential pitfall of reflectance confocal microscopy()()
por: Porto, Ana Carolina Souza, et al.
Publicado: (2019)

A STATement on Vemurafenib-Resistant Melanoma
por: Hartsough, Edward J., et al.
Publicado: (2013)

Complete remission of critical neurohistiocytosis by vemurafenib
por: Euskirchen, Philipp, et al.
Publicado: (2015)

Delayed-onset vemurafenib-induced panniculitis
por: Vance, Stephen L., et al.
Publicado: (2017)

A Rare Cause of Uveitis: Vemurafenib
por: Sızmaz, Selçuk, et al.
Publicado: (2018)

Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan
por: Uhara, H., et al.
Publicado: (2017)

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
por: Cui, Hongmei, et al.
Publicado: (2021)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance
por: Peng, Jianyu, et al.
Publicado: (2023)

BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy
por: Soares de Sá, Bianca Costa, et al.
Publicado: (2019)

Cutaneous neonatal lupus with cutis marmorata telangiectatica congenita-like lesions*
por: Trevisan, Flávia, et al.
Publicado: (2013)

Upregulation of the novel lncRNA U731166 is associated with migration, invasion and vemurafenib resistance in melanoma
por: Siena, Ádamo Davi Diógenes, et al.
Publicado: (2022)

RASopathic Skin Eruptions during Vemurafenib Therapy
por: Rinderknecht, Jeannine D., et al.
Publicado: (2013)

Vemurafenib and Dabrafenib Downregulates RIPK4 Level
por: Madej, Ewelina, et al.
Publicado: (2023)

Brazilian guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma - Part II
por: Castro, Luiz Guilherme Martins, et al.
Publicado: (2016)

Cutaneous Epithelial Tumors Induced by Vemurafenib Involve the MAPK and Pi3KCA Pathways but Not HPV nor HPyV Viral Infection
por: Frouin, Eric, et al.
Publicado: (2014)

Safety and efficacy of vemurafenib in end stage renal failure
por: Iddawela, Mahesh, et al.
Publicado: (2013)

Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
por: Rinderknecht, Jeannine D., et al.
Publicado: (2013)

Managing Side Effects of Vemurafenib Therapy for Advanced Melanoma
por: Hagen, Brenda, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_odbnr827703piet1kvot2bijle